TP53 and colon carcinoma: A study by Cooks et al. demonstrated that mutant p53, in cooperation with tumour necrosis factor-α (TNFα), prolongs NF-κB activation and results in a chronic-inflammatory phenotype and development of colon carcinoma in mutant p53 mouse models [39].